Stay updated on Risankizumab vs Placebo in Hidradenitis Suppurativa Clinical Trial
Sign up to get notified when there's something new on the Risankizumab vs Placebo in Hidradenitis Suppurativa Clinical Trial page.

Latest updates to the Risankizumab vs Placebo in Hidradenitis Suppurativa Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed, along with the removal of the funding-status notice. These are administrative updates that do not alter the study details or results presented on the page.SummaryDifference0.3%

- Check20 days agoChange DetectedAdded a notice about a lapse in government funding and NIH operating status with a link to opm.gov and cc.nih.gov. Updated page version to v3.4.1.SummaryDifference0.3%

- Check28 days agoChange DetectedUI/text updates include adding a glossary toggle and updating several labels (QC criteria wording and FEAR Act data) along with the revision/version to v3.4.0. No core study content, data, or essential functionality were altered.SummaryDifference0.1%

- Check42 days agoChange DetectedMinor revision update: Revision: v3.3.4 was added and Revision: v3.3.3 was removed, with no visible impact on study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedLocations were updated with many new sites across the US, Australia, Canada, and Europe, and numerous sites were removed. The entry also shows a page revision tag, Revision: v3.3.3.SummaryDifference3%

- Check92 days agoChange DetectedAdded a note that PubMed publications are automatically filled from PubMed. Updated the revision tag to v3.3.2.SummaryDifference0.3%

Stay in the know with updates to Risankizumab vs Placebo in Hidradenitis Suppurativa Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab vs Placebo in Hidradenitis Suppurativa Clinical Trial page.